anti-ICOSLG antibody, anti-Inducible T cell co stimulator ligand antibod, anti- .. Home » ICOSLG Products .. B7-RP1 is a 40 kD protein, also known as ICOS ligand, B7-H2, and B7h. It has recently been clustered as CD275.

superfamily, is a 40 kD protein also known as B7RP-1, B7h, B7-H2, GL50 and ICOS Ligand. Human B7-H2 is expressed by activated monocytes/macrophages and dendritic cells. .. CD275, ICOSL, B7H2, ICOS-L, B7RP-1, B7-RP1

B7RP-1, GL50, ICOSL .. ICOS

specific antibody in 200µl Target Protein Principal Names: B7-H4; B7H4; B7S1; B7X; B7h.5; FLJ22418; PRO1291; RP11- Everest Biotech Ltd 229A19. .. EB07942 (0.3µg/ml) staining of Human Spleen lysate (35µg protein in RIPA buffer).

B7-H4; B7H4; B7S1; B7X; B7h.5; FLJ22418; PRO1291; RP11-229A19. .. Calculated MW: 30878 Da

domain-containing T-cell activation inhibitor 1; Immune costimulatory protein B7-H4; B7h.5; T-cell costimulatory molecule B7x; Protein B7S1; VTCN1; B7H4 Accession No. .. KLH-conjugated synthetic peptide encompassing a sequence within the center region of

Causes arrest of mitosis and inhibits proliferation in breast cancer cell lines (GI50= 10-20 M). .. C18H16N2OS.HCl

Homo sapiens inducible T-cell co-stimulator ligand (ICOSLG) as transfection-ready DNA .. Homo sapiens DNA (cytosine-5-)-methyltransferase 3-like (DNMT3L), transcript variant 2

b>ICOSLG .. CD278 Biotin 7E.17G9 Mouse RUO

b>Icosl-594M .. Recombinant Mouse Icos Ligand, Fc-His .. Icosl, B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653, LICOS

Phycoerythrin (PE) anti-human B7RP-1 (CD275, B7-RP1, B7RP1, ICOS-L, ICOSL, B7h, GL50, B7-H2, B7H2) RUO: For Research Use Only .. Contents: Phycoerythrin (PE) anti-human B7RP-1 (CD275, B7-RP1, B7RP1, ICOS-L, ICOSL, B7h, GL50, B7-H2, B7H2)

Description: anti-GL50 .. Description: anti-GL50

GL50(ICOSL)-muIg Pur/PF Protein

2 Human CD275 (ICOSL, GL50, B7-H2) is a member of the B7 family sharing ~20% homology with CD80 (B7-1) and .. Immunogen: Human HPB-MLT cells, recombinant human CD278(ICOS)-muIg

Inducible T-cell Co-stimulator Ligand (ICOSLG) Mouse anti-Human Monoclonal (9F.8A4) Antibody .. Product Code: LS-C40799

Richter G. et al. (2001): Tumor necrosis factor -alpha regulates the expression of ICOS ligand on CD34+ progenitor cells during differentiation into antigen presenting cells. .. Temerinac S et al.

ADI ELISA kits Citation Database .. Research use notification forms for human ELISA kits .. Publications using ADI ELISA kits for human .. Publications using ADI Mouse Autoimmune ELISA kits .. Publications using ADI Animals ELISA kits

Inducible T-cell Co-stimulator Ligand (ICOSLG) Mouse anti-Human Monoclonal (2D3) Antibody .. Keratin, Type I Cytoskeletal 19 (KRT19) Mouse anti-Human Monoclonal (A53-B/A2) Antibody

014 Antibodies to ICOS (CD278) and ICOS Ligand (CD275)

1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain. .. For laboratory research only, not for drug, diagnostic or other use.

1 It produces a mean cellular antiproliferative GI50 value of 78 nM when tested against a human cancer cell line panel. .. 1 Sharp, S.Y., Prodromou, C., Boxall, K., et al.

Akbari, O., et al. (2008). ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. .. Assenmacher, M., et al. (1998).

Human BMP-7 ELISA Kit, Cat # 100-190-B7H .. BMP8 (Ab #1)

MDA 468 human cancer cell lines, potent antiproliferative activity (growth inhibition (GI50) 0.1 nM) was observed. .. 1 Mortimer, C.G., Wells, G., Crochard, J., et al. Antitumor benzothiazoles. 26.

and pros- tate cancer cell proliferationa Compd R Compd HMECb IC50 (mM) Prostate cancer GI50 (mM)c 1 2 3 4 R’ n Yield (%) (+) VEGF (À) VEGF PC-3 DU-145 2 H 0 —a 3 .. 330 S. M. Capitosti et al. / Bioorg. Med. Chem.

2 Human GL50 is a member of the B7 family sharing ~20% homology with CD80 (B7-1) and CD86 (B7-2), .. References: Beier, K.C., R.A. Kroczek, et al. 2000, Eur J Immunol. 30(12):3707-3717.

Watanabe, M. .. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. .. The Journal of Immunology.;180(8):5222-34.